HIV Rapid Test Kits Market size is expected to grow significantly from 2020 to 2026. Human immunodeficiency virus (HIV) causes Acquired Immunodeficiency Syndrome (AIDS). It is a condition that causes progressive breakdown of the immune system causing life-threatening diseases and infections to thrive. HIV infection has become a major public health concern with a prevalence rate that has increased dramatically in the past decade. It is one of the leading causes of morbidity and mortality.
Get more details on this report - Request Free Sample PDF
Increasing prevalence of HIV infection, globally, will propel the HIV rapid test kits market growth over the projected timeline. As per the Joint United Nations Programme on HIV and AIDS (UNAIDS), over 40 million people were living with HIV worldwide by the end of 2018. Thus, growing prevalence of HIV is increasing the need for effective diagnostics procedures and this will boost the HIV rapid test kits industry growth over the foreseeable years.
Advances in HIV rapid test kits technology has enabled quick turnaround time of results, thereby boosting the market growth. Medical facilities, especially point-of-care clinics use HIV rapid test kits that show the test results within a few minutes. This allows doctors to prepare a focused and effective treatment plan as per the test results. Thus, implementation of HIV rapid test kits forestalls the over-prescription of antibiotics and prevents its adverse outcomes.
Based on principle, the HIV rapid test kits market is segmented into immunochromatographic assay, nucleic acid amplification test (NAAT), and ELISA. NAAT based HIV rapid test kits accounted for significant revenue share in 2019. The growth of this segment is owing to the specificity and sensitivity provided in test results by NAAT based devices. The WHO has recognized NAAT as the primary choice for detection of various infections including HIV, thereby propelling the segmental growth.
Based on sample type, the market is categorized into blood, saliva and urine. The blood sample accounted for a major share in 2019. The growth of this segment is due to the high specificity of pathogen detection in blood. Also, the high availability of HIV rapid test kits using blood specimen for infection detection will boost the market growth over foreseeable years.
Based on end-use, the HIV rapid test kits market is segmented into hospitals, clinics, diagnostic centers, and retail pharmacies. The hospital segment is projected to witness robust growth over the analysis timeframe. Worldwide, there has been an increase in the hospital establishments. This will fuel the segmental growth over the projected timeline.
North America HIV rapid test kits market share dominated the industry in 2019 and the trend is likely to continue over the upcoming years. Increasing prevalence of HIV infection and major presence of leading market players in the region will drive the HIV rapid test kits regional market growth.
Prominent industry players operating in the HIV rapid test kits market share include Atomo Diagnostics, bioMérieux, OraSure Technologies, BioSure, Biosynex, Chembio Diagnostic Systems, Biolytical Laboratories, Sedia Biosciences Corporation, Abbott, and Hologic among others. In July 2018, Abbott introduced a new point-of-care test, the m-Pima Hiv-1/2 viral load (vl). This product launch helped the company to expand its market penetration.
By Principle, 2015-2026 (USD Million)
By Sample Type, 2015-2026 (USD Million)
By End-use, 2015-2026 (USD Million)
The above information is provided for the following regions and countries: